Changing characteristics in the 2020s of fatal ‘novel’ benzodiazepine toxicity cases in Australia
Open Access
- 18 February 2026
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 282, 113085
Abstract
No abstract availableKeywords
Funding Information
- National Drug and Alcohol Research Centre
- University of New South Wales
- National Coronial Information System
This publication has 23 references indexed in Scilit:
- Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and WalesForensic Science International, 2023
- Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022International Journal of Drug Policy, 2023
- Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UKInternational Journal of Drug Policy, 2023
- Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope / fentanyl toxicity cases in Alberta, CanadaForensic Science International, 2023
- Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020Drug and Alcohol Dependence, 2022
- What’s in fake “Xanax”? : a dosage survey of designer benzodiazepines in counterfeit pharmaceutical tabletsDrug Testing and Analysis, 2021
- Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step?Critical Reviews in Toxicology, 2021
- Quantification of Flualprazolam in Blood by LC–MS-MS: A Case Series of Nine DeathsJournal of Analytical Toxicology, 2020
- Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic CasesJournal of Analytical Toxicology, 2020
- Femoral blood concentrations of flualprazolam in 33 postmortem casesForensic Science International, 2020